자산 1
CLEO ONE
ENG KOR

News

  • Wizbiosolutions signs MOU for cooperation in the development of oral microorganism diagnostic products for oral health

    February 27 2024



  • Molecular diagnostic specialized company Wizbiosolution (CEO, Lee Hyun Young) announced the 3rd parties MOU with Industry Academic Cooperation group of SOOKMYUNG WOMEN’S University and Apple-Tree Medical Foundation at the DOCSMEDI Oralbiome Co., Ltd. conference room for the advancement of academic-industry collaboration, workforce development, and research exchange in the field of oral microbiome diagnostics for oral healthcare business. (Feb. 21st 2024)

    The signing ceremony was held and attended by Kim Hye Seong (Chairman, Apple- Tree Medical Foundation), Na Seong Sik (Advisor of Apple-Tree Medical Foundation), Lee Kook Nyung (Head of Wizbiosolution IVD device division), Sin Dong Sik (Prof. of SOOKMYUNG WOMEN’S University). 
    Under this agreement, each institution establishes collaborative research frameworks to enhance Oral and Biotech health. They plan to carry forward research cooperation through joint product development, and clinical research to build up a mutually beneficial research collaboration system. 
    Utilizing its strength in Ready-to-Use lyophilized molecular diagnostic reagent technology and PCR enzymes production facility with GMP certified, Wizbiosolution is expected to contribute to improving oral healthcare emphasizing the value of "Chewing and enjoying food is the foundation of a healthy life“ by integrating user-friendly molecular diagnostic platform products into oral healthcare management.